Scutellaria baicalensis extract is quoted at anything from 6% to 98% baicalin, and buyers read the number as a ranking. It is not one. Plamed standardises PCR® Supermolecule Scutellaria Baicalensis Extract at ≥6% baicalin for oily, sensitive skin, and this note sets out the three endpoints that choice rests on — and how to read the number attached to each.
Specification | Value |
Trade name | PCR® Supermolecule Scutellaria Baicalensis Extract |
Marker | Baicalin ≥6% |
INCI | Scutellaria Baicalensis Root Extract, Hydroxypropyl Cyclodextrin |
Composition | Water-soluble powder, typically 15% extract on 85% hydroxypropyl cyclodextrin |
Recommended use level | 0.5–2.35% |
Suggested pH | 5–7; precipitation is seen at pH 8–10 |
Endpoints available | 5-alpha reductase and SZ95 sebocyte lipid droplets (in vitro); skin haemoglobin in a 16-person infrared challenge; IL-6, IL-1β and PGE2 release plus a zebrafish model; a 30-person patch test |
Why 85% and 6% Are Two Different Products
Baicalin content is set by how far the extract is purified, not by how good the plant was: a 98% grade and a 6% grade are two products made to two specifications, and neither is a corrected version of the other. Scutellaria baicalensis root contains a family of flavonoids — baicalin, baicalein, wogonin, oroxylin A — and pushing one of them to 85% or 98% means removing most of the others. That is chemistry rather than a defect: a high-baicalin grade is a purified single-marker material, while a 6% grade is a broader extract carried on a solubiliser so that it disperses in water.
The two are built for different jobs. A purified high-baicalin powder suits brightening and antioxidant positioning, where the active is one molecule and the formula can carry a powder that needs solubilising. An oily, sensitive skin brief needs something else: evidence that the material acts on sebum, on the mediators behind low-grade irritation, and on visible redness. Plamed built this product for the second job and specified the marker to match it.
The percentage answers how much baicalin is in the drum. It does not answer whether the material does anything at the use level in a formula. Those are separate questions, and only the second one is settled by endpoint data.
Three Jobs for Oily, Sensitive Skin: Oil, Inflammation, Redness
Oily, sensitive skin is not one problem. It is three that arrive together: sebum output is high, the skin sits in a state of low-grade irritation, and redness shows at the surface. Each of the three has its own measurement, and no single percentage covers all three.
Sebum output is measured either at the signal that drives it — 5-alpha reductase converting testosterone into DHT — or at the product, as lipid accumulation inside sebocytes. Irritation is measured as cytokine and prostaglandin release in cell culture, or as a response in a whole organism. Redness is measured on people with an instrument, because it is a colour and a blood-content change rather than a sensation.
A specification figure is an input. Each of the three is an output. Buyers who compare extracts on baicalin content are comparing inputs, and inputs do not predict outputs across different materials.
Plamed's ordering rule for this extract is to fix the job first: decide whether the formula needs oil handled, comfort restored, or visible redness addressed, then ask for the endpoint that belongs to that job. One endpoint that matches the brief is worth more than a marker figure that matches nothing.
Oil Control: Two Numbers, Not One
Oil control for a Scutellaria baicalensis extract is claimed at two levels — an enzyme inhibition rate inside the sebocyte, and a lipid-droplet reduction in culture — and a supplier who hands over only one of the two is handing over half the picture.
The first is enzymatic. 5-alpha reductase type 1 converts testosterone into DHT inside sebocytes, and DHT is the signal that raises sebum production, so an inhibitor of that enzyme lowers the signal. An in vitro inhibition rate on this enzyme is a clean and inexpensive number, and it is also the easiest one to over-read, because it is measured in a tube with an isolated enzyme and a fixed substrate rather than on skin.
The second is cellular. Sebocytes in culture accumulate lipid droplets, and a test article that reduces neutral lipid staining is acting at the product end of the same pathway. That is closer to sebum and still not sebum on a face: a sebocyte monolayer has no stratum corneum, no microbiome and no hormonal background.
In an enzyme assay, Plamed's PCR® Supermolecule Scutellaria Baicalensis Extract inhibited 5-alpha reductase by 16.00%, 56.71% and 69.41% at concentrations of 0.1%, 0.5% and 1%, respectively, against the blank control (Guangdong Yaoda Testing). In SZ95 sebocytes challenged with DHT, the same extract reduced lipid-droplet staining by 28.93%, 37.42%, 41.57% and 51.33% at 0.008%, 0.016%, 0.031% and 0.063% (Shanghai Weipu Testing). A 0.5% PCA-zinc control run in the same enzyme assay reached 40.24%. Plamed reports the pair rather than one, because it describes the pathway in order — signal first, product second. Neither figure is a percentage of oil reduction on skin, and a supplier who presents an enzyme inhibition rate as "oil control by X%" has moved a tube result onto a face. Readers should ask which of the two a quoted number is, and at what concentration it was measured: inhibition curves for this class of extract are steep at the low end and flatten quickly, so a value without its concentration cannot be compared with anything.
Where a brief needs a claim that lives on skin, the endpoint behind it is a sebum measurement on volunteers, over several weeks, with a stated sampling method. Plamed does not hold that endpoint for this extract, and writes the claim only where the endpoint exists.
Redness: A Human Test with Instrument Endpoints
Redness is the one endpoint in this set that was measured on people, and that changes what can safely be said about it: an instrument reading on deliberately challenged skin supports a redness claim in a way that a volunteer's description of comfort cannot.
In an independent human study at NOA Testing, Plamed's PCR® Supermolecule Scutellaria Baicalensis Extract was evaluated at 1% following infrared-induced erythema on the forearm. Skin haemoglobin was measured with a Mexameter MX18 at one and two hours in 16 volunteers. Haemoglobin is the right variable for redness: visible colour follows blood content in the upper dermis, so an instrument reading sits closer to what a consumer sees than a visual grade by a technician.
In that test, 1% of PCR® Supermolecule Scutellaria Baicalensis Extract took the erythema index from 311 after challenge to 235 at one hour and 226 at two hours — a fall of 24.44% and then 27.33% (n=16). One hour is early, and the timing is a feature rather than a limitation: it separates a material that acts on the vessel response from one that only feels cooling.
Plamed keeps four boundaries attached to that sentence. It is a single application, at 1%, on deliberately challenged skin, read at one and two hours; the study reports no untreated control area, so the figures are falls from the post-challenge baseline rather than differences from a vehicle; it says nothing about daily use over months; and it does not transfer to another concentration, because no dose-response was run on this endpoint.
This is also where "redness" and "soothing" part company. A soothing claim can rest on what volunteers report feeling. A redness claim needs an instrument, a provocation and a time point. Both are legitimate evidence; they are not the same evidence, and a specification sheet rarely distinguishes them.
Inflammation: Three Mediators and a Whole-Animal Model
The irritation side of oily, sensitive skin is usually summarised with a single number, but three mediators — IL-6, IL-1β and PGE2 — sit at three different points in one NF-κB-driven response, and each can move independently of the others.
NF-κB activation drives transcription of IL-6, IL-1β and PGE2, and each of the three reports a different part of the cascade: IL-6 is the broad acute-phase signal, IL-1β the early one, and PGE2 the prostaglandin arm that carries much of the visible and sensory component. A test article can move one of them and leave the others where they were, so a single figure chosen because it is the largest is not a summary of the material — it is a summary of the assay that flattered it.
In an independent mediator assay, Plamed's PCR® Supermolecule Scutellaria Baicalensis Extract at 0.5% (Shaanxi Biocell) inhibited IL-6 by 96.87%, IL-1β by 77.80% and PGE2 by 91.09% against the stimulated control in a single run, making the differences between the three responses visible. Where a supplier quotes one inhibition rate for "inflammation", the useful follow-up is which mediator it belongs to, and whether the other two were measured in the same experiment.
The whole-organism point matters for a different reason. At 0.1%, Plamed's PCR® Supermolecule Scutellaria Baicalensis Extract reduced the inflammatory response by 87% in a zebrafish model (Hunter Biotechnology, p<0.001), an integrated response — vessels, immune cells and tissue in one living animal — and it is the one endpoint in this set that is neither a tube nor a monolayer. It is also not a human result, and Plamed does not present it as one: what a fish shows is that a response can be modulated in a living system, not that a cream will calm a face.
The boundary is the one that applies to every in vitro figure here. Cell culture at 0.5% does not become a finished-formula claim at whatever percentage ends up in the jar.
Seven Questions for Any Scutellaria Supplier
Seven questions decide whether a Scutellaria baicalensis extract fits an oily, sensitive formula. The first five are about endpoints, not about the baicalin percentage — which is the one thing every supplier can already answer. The last two are about the paperwork that makes the first five usable.
1. Which of the three jobs is this material for? An answer of "all of them" usually means no endpoint was chosen, and that the supplier is describing the plant rather than the product.
2. Is there endpoint data for that job, in a report you can send? A number in a brochure with no report behind it is a claim, not data.
3. At what concentration, in which model, over what time? An inhibition rate without its concentration cannot be compared with anything, and a cell result without its model cannot be compared with a human one.
4. How is the marker defined? "Baicalin 6%" means the sum of baicalin and its glycosides by a stated HPLC method, or it means very little.
5. Will it dissolve and hold at the pH of my formula? For a water-soluble grade the answers are solubility, a pH window and a maximum use level. Plamed publishes ≥6% baicalin, water solubility, a suggested pH of 5 to 7 with precipitation at 8 to 10, a use level of 0.5% to 2.35%, and an independent 48-hour patch test at 2.35% on 30 volunteers (NOA Testing) with no reactions at any reading, so a formulator can check the fit before requesting a sample.
6. What should arrive with the sample? A specification that states the baicalin figure and the HPLC method behind it, the INCI declaration including the carrier, the CAS numbers, and a batch COA issued against that same specification. Those four decide whether a sample is worth requesting at all.
7. Will the COA match the specification you were shown? A COA issued against a different specification than the published one means the buyer is comparing two products under one name. Plamed issues the COA against the specification published for this product, batch by batch.
The order matters. A buyer who asks the first question will often find that the second and third answers rule the material out, which is cheaper than discovering it in a stability trial eight weeks later.
Where this does not apply: a brief that needs a single brightening or antioxidant marker is better served by a purified high-baicalin grade, and Plamed points those briefs at a purified grade rather than at this one. The material described here was built for the oily, sensitive case, and Plamed expects it to be judged on the endpoints above — not on how its marker figure compares with a product designed for something else. Full study reports are available to qualified formulators on request.
